Trials / Unknown
UnknownNCT01476020
Is There A LIfe for Drug Eluting Stent (DES) After Discontinuation of Clopidogrel
Is There A LIfe for DES After Discontinuation of Clopidogrel:The ITALIC PLUS Trial
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,240 (estimated)
- Sponsor
- Gilard, Martine · Individual
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The ITALIC PLUS Trial was designed with the objective of extending to other countries the enrollment of patients into the ITALIC trial initially conducted in France, in order to achieve statistical significance by pooling the data of both trials.
Detailed description
The use of drug-eluting stents has resulted in a significant reduction in the restenosis rate and in the need for repeat angioplasty of the stented lesion. However, the occurrence of late stent thrombosis has resulted in an increase in the duration of dual antiplatelet treatment. According to the guidelines of the ESC, the current recommended duration of dual antiplatelet treatment is 12 months. A relationship has been demonstrated between the occurrence of late stent thrombosis and aspirin resistance. Furthermore, dual anti-platelet treatment is associated with an increase in bleeding, the severity of which has been well documented. In addition, the patients involved, and especially those over 70, have significant co-morbidities often requiring extra-cardiac surgery which cannot easily be carried out in patients on dual antiplatelet treatment or clopidogrel. The objective of this study is to determine whether, after a period of 6 months following Drug eluting stent (DES) implantation in patients regarded as sensitive to aspirin, dual antiplatelet therapy may be replaced by aspirin alone. The original Italic Trial is a multicenter, randomized study evaluating the non-inferiority of aspirin as a single treatment versus dual antiplatelet therapy with clopidogrel and aspirin 6 months after drug-eluting stent implantation, including a 12-, 24- and 36-month follow-up analysis.
Conditions
Timeline
- Start date
- 2011-11-01
- Primary completion
- 2012-07-01
- Completion
- 2015-07-01
- First posted
- 2011-11-22
- Last updated
- 2011-11-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01476020. Inclusion in this directory is not an endorsement.